Bristol-Myers Squibb Australia Pty Ltd

Filters applied:

2017

Clear all

18 result(s) found, displaying 1 to 10

AusPAR: Nivolumab

15 November 2017

Australian public assessment report (AusPar)

Australian Public Assessment Report for Nivolumab
Notice for nivolumab (Bristol-Myers Squibb Australia Pty Ltd)

10 November 2017

Designation or determination

Priority review
AusPAR: Nivolumab

9 November 2017

Australian public assessment report (AusPar)

Nivolumab [Opdivo]
AusPAR: Elotuzumab

31 October 2017

Australian public assessment report (AusPar)

Australian Public Assessment Report for Elotuzumab
Notice for nivolumab (Bristol-Myers Squibb Australia Pty Ltd)

28 September 2017

Designation or determination

Priority review
VUMON teniposide 50mg/5mL injection ampoule Cancelled under s30(1)(c)

22 June 2017

Cancellation by sponsor

Requested by Bristol-Myers Squibb Australia Pty Ltd
MONOPRIL fosinopril sodium 20mg tablet blister pack Cancelled under s30(1)(c) of the Act

20 April 2017

Cancellation by sponsor

Requested by Bristol-Myers Squibb Australia Pty Ltd
MONOPRIL fosinopril sodium 20mg tablet bottle Cancelled under s30(1)(c) of the Act

20 April 2017

Cancellation by sponsor

Requested by Bristol-Myers Squibb Australia Pty Ltd
MONOPLUS 10/12.5 fosinopril 10mg and hydrochlorothiazide 12.5mg tablets blister pack Cancelled under s30(1)(c) of the Act

5 April 2017

Cancellation by sponsor

Requested by Bristol-Myers Squibb Australia Pty Ltd
MONOPLUS 10/12.5 fosinopril 10mg and hydrochlorothiazide 12.5mg tablets bottle Cancelled under s30(1)(c) of the Act

5 April 2017

Cancellation by sponsor

Requested by Bristol-Myers Squibb Australia Pty Ltd

Sub menu

Product regulation

Safety and shortages

Resources and guidance

Business services

Bristol-Myers Squibb Australia Pty Ltd

AusPAR: Nivolumab

Notice for nivolumab (Bristol-Myers Squibb Australia Pty Ltd)

AusPAR: Nivolumab

AusPAR: Elotuzumab

Notice for nivolumab (Bristol-Myers Squibb Australia Pty Ltd)

VUMON teniposide 50mg/5mL injection ampoule Cancelled under s30(1)(c)

MONOPRIL fosinopril sodium 20mg tablet blister pack Cancelled under s30(1)(c) of the Act

MONOPRIL fosinopril sodium 20mg tablet bottle Cancelled under s30(1)(c) of the Act

MONOPLUS 10/12.5 fosinopril 10mg and hydrochlorothiazide 12.5mg tablets blister pack Cancelled under s30(1)(c) of the Act

MONOPLUS 10/12.5 fosinopril 10mg and hydrochlorothiazide 12.5mg tablets bottle Cancelled under s30(1)(c) of the Act

Bristol-Myers Squibb Australia Pty Ltd

Type

Date